未登录

J

Jordi Riba

autonomous university of barcelona

H指数:53

被引数:9,781

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sarah Kofman in the debate on the existentialist morality

莎拉·科夫曼在存在主义道德辩论中的观点

Anales del Seminario de Historia de la Filosofia

IF0.2

2026-01-010

PRE

The role of opioid transmission in music-induced pleasure

阿片类药物在音乐引起的快感中的作用

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES

IF4.8

2022-12-139

OAAI

Preliminary evidence of links between ayahuasca use and the corpus callosum

ayahuasca使用与call体之间联系的初步证据

FRONTIERS IN PSYCHIATRY

IF3.2

2022-10-264

OAAI

Dopamine modulations of reward-driven music memory consolidation

多巴胺对奖赏驱动的音乐记忆巩固的调节

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES

IF4.8

2021-07-1131

PREAI

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats

PSYCHOPHARMACOLOGY

IF3.3

2021-03-1076

OAAI

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo

TRANSLATIONAL PSYCHIATRY

IF6.2

2020-09-2891

OAAI

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

PSYCHOPHARMACOLOGY

IF3.3

2019-12-1070

OAAI

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms

PSYCHOPHARMACOLOGY

IF3.3

2019-04-13121

OAAI

Dopamine modulates the reward experiences elicited by music

多巴胺调节音乐引起的奖励体验

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2019-01-22197

OAAI

Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits

PSYCHOPHARMACOLOGY

IF3.3

2018-11-0758

PREAI

Intrinsically regulated learning is modulated by synaptic dopamine signaling

IF0

2018-08-3037

OAAI

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution

PSYCHOPHARMACOLOGY

IF3.3

2018-08-13156

OAAI

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

迷幻的ayahuasca在难治性抑郁症中的快速抗抑郁作用: 一项随机安慰剂对照试验

PSYCHOLOGICAL MEDICINE

IF5.5

2018-06-15341

OAAI

Palhano-Fontes, Fernanda; Barreto, Dayanna; Onias, Heloisa; Andrade, Katia C.; Novaes, Morgana M.; Pessoa, Jessica A.; Mota-Rolim, Sergio A.; Osorio, Flavia L.; Sanches, Rafael; dos Santos, Rafael G.; Tofoli, Luis Fernando; Silveira, Gabriela de Oliveira; Yonamine, Mauricio; Riba, Jordi; Santos, Francisco R.; Silva-Junior, Antonio A.; Alchieri, Joao C.; Galvao-Coelho, Nicole L.; Lobao-Soares, Bruno; Hallak, Jaime E. C.; Arcoverde, Emerson; Maia-de-Oliveira, Joao P.; Araujo, Draulio B.

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro

SCIENTIFIC REPORTS

IF3.9

2017-07-13122

OAAI

Ayahuasca enhances creative divergent thinking

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-010

PREAI

Neurophysiological effects of psychedelics in humans

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-10-010

PREAI

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

FRONTIERS IN NEUROSCIENCE

IF3.2

2016-09-1488

OAAI

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

Ayahuasca: 药理学，神经科学和治疗潜力

BRAIN RESEARCH BULLETIN

IF3.7

2016-09-01158

PREAI

Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking

PSYCHOPHARMACOLOGY

IF3.3

2016-07-19142

OAAI

Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2016-07-01132

OAAI